Komzifti

Active Ingredient(s): Ziftomenib
FDA Approved: * November 13, 2025
Pharm Company: * KURA
Category: Cancer
* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Komzifti 200 mg Oral Capsule
NDC: 84696-200
Labeler:
Kura Oncology, Inc.